表紙
市場調查報告書

心臟切除裝置 - 醫療設備的開發平台評估:2020年

Cardiac Ablation Devices - Medical Devices Pipeline Assessment, 2020

出版商 GlobalData 商品編碼 960886
出版日期 內容資訊 英文
訂單完成後即時交付
價格
心臟切除裝置 - 醫療設備的開發平台評估:2020年 Cardiac Ablation Devices - Medical Devices Pipeline Assessment, 2020
出版日期: 2020年09月01日內容資訊: 英文
簡介

心臟切除裝置,是使用無線電頻率(射頻)能源的設備,傳播不正的電力訊號引起異常的心律破壞心臟組織。

本報告提供心臟切除裝置的開發中產品調查分析,以各開發階段比較分析為焦點,包含開發產品的主要企業,進行中的臨床試驗相關資訊等系統性資訊。

目錄

第1章 目錄

第2章 簡介

第3章 開發中的產品

  • 心臟切除裝置 - 開發中產品:各開發階段
  • 心臟切除裝置 - 開發中產品:各地區
  • 心臟切除裝置 - 開發中產品:各法規途徑
  • 心臟切除裝置 - 開發中產品:各核准預定日
  • 心臟切除裝置 - 進行中的臨床試驗

第4章 心臟切除裝置 - 開發中的開發中產品:各企業

  • 心臟切除裝置企業 - 開發中產品:各開發階段
  • 心臟切除裝置 - 開發中產品:各開發階段

第5章 心臟切除裝置企業與產品概要

  • AblaCor Medical Corporation
  • Adagio Medical Inc.
  • AFreeze GmbH
  • AngioDynamics Inc
  • Atrian Medical Ltd
  • AtriCure Inc
  • Baylis Medical Company Inc
  • Corfigo Inc
  • Coridea, LLC
  • CPSI Biotech
  • Ethicon US LLC
  • Helical Solutions, Inc. (暫停中)
  • Imricor Medical Systems Inc
  • Johns Hopkins University
  • Kardium Inc
  • LuxCath, LLC
  • Medtronic Plc
  • Northwestern University
  • Sheba Medical Center
  • Spectranetics Corp
  • Thermedical Inc
  • Tufts Medical Center
  • University of California Los Angeles
  • University of Chicago
  • VytronUS Inc

第6章 心臟切除裝置 - 最近的開發

第7章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0986EPD

GlobalData's Medical Devices sector report, "Cardiac Ablation Devices - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Cardiac Ablation Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Cardiac Ablation Devices are devices that use radiofrequency energy to destroy cardiac tissues which propagate incorrect electrical signals to cause an abnormal heart rhythm.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Cardiac Ablation Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Cardiac Ablation Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Cardiac Ablation Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Cardiac Ablation Devices Overview

3 Products under Development

  • 3.1 Cardiac Ablation Devices - Pipeline Products by Stage of Development
  • 3.2 Cardiac Ablation Devices - Pipeline Products by Territory
  • 3.3 Cardiac Ablation Devices - Pipeline Products by Regulatory Path
  • 3.4 Cardiac Ablation Devices - Pipeline Products by Estimated Approval Date
  • 3.5 Cardiac Ablation Devices - Ongoing Clinical Trials

4 Cardiac Ablation Devices - Pipeline Products under Development by Companies

  • 4.1 Cardiac Ablation Devices Companies - Pipeline Products by Stage of Development
  • 4.2 Cardiac Ablation Devices - Pipeline Products by Stage of Development

5 Cardiac Ablation Devices Companies and Product Overview

  • 5.1 AblaCor Medical Corporation Company Overview
    • 5.1.1 AblaCor Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2 Adagio Medical Inc. Company Overview
    • 5.2.1 Adagio Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3 AFreeze GmbH Company Overview
    • 5.3.1 AFreeze GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4 AngioDynamics Inc Company Overview
    • 5.4.1 AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5 Atrian Medical Ltd Company Overview
    • 5.5.1 Atrian Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6 AtriCure Inc Company Overview
    • 5.6.1 AtriCure Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7 Baylis Medical Company Inc Company Overview
    • 5.7.1 Baylis Medical Company Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8 Corfigo Inc Company Overview
    • 5.8.1 Corfigo Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9 Coridea, LLC Company Overview
    • 5.9.1 Coridea, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10 CPSI Biotech Company Overview
    • 5.10.1 CPSI Biotech Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11 Ethicon US LLC Company Overview
    • 5.11.1 Ethicon US LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12 Helical Solutions, Inc. (Inactive) Company Overview
    • 5.12.1 Helical Solutions, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13 Imricor Medical Systems Inc Company Overview
    • 5.13.1 Imricor Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14 Johns Hopkins University Company Overview
    • 5.14.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15 Kardium Inc Company Overview
    • 5.15.1 Kardium Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16 LuxCath, LLC Company Overview
    • 5.16.1 LuxCath, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17 Medtronic Plc Company Overview
    • 5.17.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18 Northwestern University Company Overview
    • 5.18.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.19 Sheba Medical Center Company Overview
    • 5.19.1 Sheba Medical Center Pipeline Products & Ongoing Clinical Trials Overview
  • 5.20 Spectranetics Corp Company Overview
    • 5.20.1 Spectranetics Corp Pipeline Products & Ongoing Clinical Trials Overview
  • 5.21 Thermedical Inc Company Overview
    • 5.21.1 Thermedical Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.22 Tufts Medical Center Company Overview
    • 5.22.1 Tufts Medical Center Pipeline Products & Ongoing Clinical Trials Overview
  • 5.23 University of California Los Angeles Company Overview
    • 5.23.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview
  • 5.24 University of Chicago Company Overview
    • 5.24.1 University of Chicago Pipeline Products & Ongoing Clinical Trials Overview
  • 5.25 VytronUS Inc Company Overview
    • 5.25.1 VytronUS Inc Pipeline Products & Ongoing Clinical Trials Overview

6 Cardiac Ablation Devices- Recent Developments

7 Appendix

List of Tables

List of Tables

  • Table 1: Cardiac Ablation Devices - Pipeline Products by Stage of Development
  • Table 2: Cardiac Ablation Devices - Pipeline Products by Territory
  • Table 3: Cardiac Ablation Devices - Pipeline Products by Regulatory Path
  • Table 4: Cardiac Ablation Devices - Pipeline Products by Estimated Approval Date
  • Table 5: Cardiac Ablation Devices - Ongoing Clinical Trials
  • Table 6: Cardiac Ablation Devices Companies - Pipeline Products by Stage of Development
  • Table 7: Cardiac Ablation Devices - Pipeline Products by Stage of Development
  • Table 8: AblaCor Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 9: AutoBlator - Product Status
  • Table 10: AutoBlator - Product Description
  • Table 11: CircumBlator AF Catheter Ablation System - Product Status
  • Table 12: CircumBlator AF Catheter Ablation System - Product Description
  • Table 13: Adagio Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 14: iCLAS System - Product Status
  • Table 15: iCLAS System - Product Description
  • Table 16: Adagio Medical Inc. - Ongoing Clinical Trials Overview
  • Table 17: iCLAS System - A Prospective, Multicenter Investigation of the Adagio Cryoablation System in Patients with Atrial Fibrillation
  • Table 18: iCLAS System - iCLAS for Persistent Atrial Fibrillation
  • Table 19: AFreeze GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • Table 20: CoolLoop - Product Status
  • Table 21: CoolLoop - Product Description
  • Table 22: Tip-Catheter - Product Status
  • Table 23: Tip-Catheter - Product Description
  • Table 24: AFreeze GmbH - Ongoing Clinical Trials Overview
  • Table 25: CoolLoop - Treatment Success with the CoolLoop Cryoablation System - Post-Market Surveillance
  • Table 26: AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 27: Non-Thermal Vein Ablation Device - Product Status
  • Table 28: Non-Thermal Vein Ablation Device - Product Description
  • Table 29: Atrian Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 30: mPEF Device - Atrial Fibrillation - Product Status
  • Table 31: mPEF Device - Atrial Fibrillation - Product Description
  • Table 32: AtriCure Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 33: AtriCure Bipolar System - Product Status
  • Table 34: AtriCure Bipolar System - Product Description
  • Table 35: Isolator Synergy Encompass Clamp - Product Status
  • Table 36: Isolator Synergy Encompass Clamp - Product Description
  • Table 37: AtriCure Inc - Ongoing Clinical Trials Overview
  • Table 38: AtriCure Bipolar System - Combined Endoscopic Epicardial and Percutaneous Endocardial Ablation Versus Repeated Catheter Ablation in Persistent and Longstanding Persistent Atrial Fibrillation
  • Table 39: Baylis Medical Company Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 40: Cardiac Ablation Mitigating Device - Product Status

List of Figures

List of Figures

  • Figure 1: Cardiac Ablation Devices - Pipeline Products by Stage of Development
  • Figure 2: Cardiac Ablation Devices - Pipeline Products by Territory
  • Figure 3: Cardiac Ablation Devices - Pipeline Products by Regulatory Path
  • Figure 4: Cardiac Ablation Devices - Pipeline Products by Estimated Approval Date
  • Figure 5: Cardiac Ablation Devices - Ongoing Clinical Trials